Cited by 432Retinoids in leukemia and cellular processesEpigenetics and DNA MethylationPeroxisome Proliferator-Activated Receptors

The Human Tumor Antigen PRAME Is a Dominant Repressor of Retinoic Acid Receptor Signaling

Open access
Epping, Mirjam T., Wang, Liming, Edel, Michael J., Carlée, Leone, Hernandez, Maria, Bernards, René·2005·Cell

Abstract

Retinoic acid (RA) induces proliferation arrest, differentiation, and apoptosis, and defects in retinoic acid receptor (RAR) signaling have been implicated in cancer. The human tumor antigen PRAME is overexpressed in a variety of cancers, but its function has remained unclear. We identify here PRAME as a dominant repressor of RAR signaling. PRAME binds to RAR in the presence of RA, preventing ligand-induced receptor activation and target gene transcription through recruitment of Polycomb proteins. PRAME is present at RAR target promoters and inhibits RA-induced differentiation, growth arrest, and apoptosis. Conversely, knockdown of PRAME expression by RNA interference in RA-resistant human melanoma restores RAR signaling and reinstates sensitivity to the antiproliferative effects of RA in vitro and in vivo. Our data suggest that overexpression of PRAME frequently observed in human cancers confers growth or survival advantages by antagonizing RAR signaling.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2005.07.003

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In contrast to the classical p160 coregulators, RIP140 and PRAME inhibit the transcriptional activity of RARs through the recruitment of HDACs and PcG proteins respectively.

    “In contrast to the classical p160 coregulators, RIP140 and PRAME inhibit the transcriptional activity of RARs through the recruitment of HDACs ( 108 ) and PcG proteins ( 63 ) respectively.”
  • At the end of the transcriptional response, liganded RARs have been shown to recruit unconventional coregulators with LxxLL motifs, such as RIP140 and PRAME.

    “At the end of the transcriptional response, liganded RARs have been shown to recruit unconventional coregulators with LxxLL motifs, such as RIP140 and PRAME ( Fig. 4C ).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Epping, M. T., Wang, L., Edel, M. J., Carlée, L., Hernandez, M., & Bernards, R.
Affiliations
The Netherlands Cancer Institute (NL)
Corresponding author
Bernards, René
Venue
Cell
Publisher
Elsevier BV
Published
2005-09
Volume
122
Issue
6
Pages
835-847
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2125685908
Cited by
432
References
3
Citations by year
2026: 14 · 2025: 19 · 2024: 27 · 2023: 35 · 2022: 27 · 2021: 20 · 2020: 25 · 2019: 16 · 2018: 14 · 2017: 12 · 2016: 18 · 2015: 18 · 2014: 15 · 2013: 26 · 2012: 15
FWCI
7.81
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
PRAME, retinoic acid receptor signaling, retinoic acid, tumor antigens, Polycomb group proteins, transcriptional repression, melanoma, retinoic acid resistance, apoptosis, cell differentiation
MeSH terms
Enhancer of Zeste Homolog 2 Protein, Animals, Antigens, Neoplasm, Cell Differentiation, DNA-Binding Proteins, Humans, Ligands, Melanoma, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Protein Binding, Repressor Proteins, Sensitivity and Specificity, Transcription Factors, Transplantation, Heterologous, Tretinoin, Signal Transduction, Apoptosis, Receptors, Retinoic Acid, RNA Interference, Cell Line, Tumor, Cell Proliferation, Mice, Polycomb Repressive Complex 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review